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Electrocardiographic Comparison of ARVD/C and RVOT Arrhythmias August 16, 2011:831–8Electrocardiographic Comparison of Ventricular Arrhythmias in
Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
and Right Ventricular Outflow Tract Tachycardia
Objectives The purpose of this study was to evaluate whether electrocardiographic characteristics of ventricular arrhythmias
distinguish patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) from those with
right ventricular outflow tract tachycardia (RVOT-VT).
Background Ventricular arrhythmias in RVOT-VT and ARVD/C-VT patients can share a left bundle branch block/inferior axis
morphology.
Methods We compared the electrocardiographic morphology of ventricular tachycardia or premature ventricular contrac-
tions with left bundle branch block/inferior axis pattern in 16 ARVD/C patients with that in 42 RVOT-VT patients.
Results ARVD/C patients had a significantly longer mean QRS duration in lead I (150  31 ms vs. 123  34 ms,
p  0.006), more often exhibited a precordial transition in lead V6 (3 of 17 [18%] vs. 0 of 42 [0%] with RVOT-VT,
p  0.005), and more often had at least 1 lead with notching (11 of 17 [65%] vs. 9 of 42 [21%], p  0.001).
The most sensitive characteristics for the detection of ARVD/C were a QRS duration in lead I of 120 ms (88%
sensitivity, 91% negative predictive value). QRS transition at V6 was most specific at 100% (100% positive pre-
dictive value, 77% negative predictive value). The presence of notching on any QRS complex had 79% sensitivity
and 65% specificity of (55% positive predictive value, 85% negative predictive value). In multivariate analysis,
QRS duration in lead I of 120 ms (odds ratio [OR]: 20.4, p  0.034), earliest onset QRS in lead V1 (OR:
17.0, p  0.022), QRS notching (OR: 7.7, p  0.018), and a transition of V5 or later (OR: 7.0, p  0.030)
each predicted the presence of ARVD/C.
Conclusions Several electrocardiographic criteria can help distinguish right ventricular outflow tract arrhythmias originating
from ARVD/C compared with RVOT-VT patients. (J Am Coll Cardiol 2011;58:831–8) © 2011 by the American
College of Cardiology FoundationArrhythmogenic right ventricular dysplasia/cardiomyopathy
(ARVD/C) is an inherited disease characterized by a progressive
replacement of myocytes of the right ventricle with fibrous and
fatty tissue (1,2). The clinical spectrum is diverse, and ventric-
ular tachycardia (VT) and sudden cardiac death are hallmarks
of the disease (1–4).
In contrast, right ventricular outflow tract tachycardia
(RVOT-VT) is the most common cause of idiopathic VT
and is a relatively benign condition. Treatment with abla-
tion is frequently recommended, with a success rate 90%
(5,6). VTs from this region also share a left bundle branch
block (LBBB) QRS morphology/inferior axis pattern, and
differentiation between these 2 distinct disease states is
paramount. The presence of T-wave inversion in V1 to V3 in
normal sinus rhythm may aid the diagnosis of ARVD/C, but
recent data showed that these changes may be present in only
32% of ARVD/C patients as well as 1% to 3% of normal young
patients (7–10). Similarly, other popular noninvasive studies
show a 50% to 60% false-negative rate (echocardiography),
and a 70% false-positive rate (magnetic resonance imaging
[MRI]) for the diagnosis of ARVD/C (10,11). It is there-
fore important for the clinician to distinguish ventricular
arrhythmias of an LBBB QRS morphology/inferior axis
RVOT ventricular arrhythmia from those that occur due to
ARVD/C.
The purpose of our study was to determine whether surface
electrocardiographic characteristics could distinguish patientswith RVOT-VT from patients with ARVD/C-VT with an
LBBB and an inferior QRS axis pattern by analysis of
electrocardiographic characteristics.
Methods
Patients. Electrocardiograms (ECGs) from patients with
ARVD/C were selected from 2 cohorts: 13 patients from
the North American ARVD Registry with confirmed
ARVD/C by the core laboratory and 3 patients from the
Madras Medical Mission, Chennai, Tamil Nadu, India. All
patients had confirmed ARVD/C based on the revised task
force criteria (10,12). Only patients presenting with a
ventricular arrhythmia characterized by an LBBB pattern
and inferior axis were included. Electrocardiographic trac-
ings were excluded if they were of poor quality, if they
displayed fewer than 10 leads, or if VT was too rapid
(preceding T-wave interfering with subsequent QRS) to
allow precise measurements of the QRS onset. Because
ARVD/C patients may have several morphologies of VT or
premature ventricular contractions (PVCs), we analyzed
each morphology as a distinct data entry. One of the
ARVD/C patients had 2 distinct morphologies. Thus, there
were 17 different data entries for ARVD/C patients.
The RVOT-VT cohort consisted of 42 consecutive
patients with RVOT-VT successfully treated with abla-
tion. All patients with RVOT-VT had structurally nor-
mal hearts as assessed by physical examination and
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August 16, 2011:831–8 Electrocardiographic Comparison of ARVD/C and RVOT Arrhythmiasechocardiography (and/or MRI). Patients with a diagno-
sis of RVOT-VT were included if they had at least one
12-lead electrocardiographic tracing with spontaneous
PVCs or VT.
Electrocardiographic analysis. We used ECGs that were
recorded with at least 10 simultaneous leads. The ampli-
tudes were 1 mV/cm. For digital analysis, hard copies of the
ECGs were scanned on a flat bed scanner at a resolution of
600 dpi and processed in Adobe Photoshop CS version 8
(Adobe Systems Incorporated, San Jose, California) by
changing the size to 200 pixels/cm, rendering the ECGs to
500 pixels/s if they were originally recorded at 25 mm/s.
Two investigators made measurements blinded to the diag-
nosis. The time difference from the lead with earliest QRS
onset to the onsets for each lead was measured. If more than
1 lead shared a simultaneous onset with the lead determined
to be earliest, they were all determined to be of earliest
onset. We also measured earliest onset of QRS to initial
peak/nadir of each lead and QRS duration for each lead
(Fig. 1). We measured QRS notching (a deflection of 0.5
mV on the QRS that did not cross baseline) (Fig. 2) and the
precordial R-to-S wave transition, defined as the precordial
lead where R-wave amplitude was equal to or greater than
the S-wave amplitude.
Data analysis. Continuous variables are expressed as mean
SD if normally distributed and median and interquartile
range if not normally distributed. The Wilcoxon rank sum
test was used to compare continuous variables. Categorical
variables were compared using the chi-square test statistic.
We assessed interobserver agreement for binary outcomes
using the kappa statistic and for continuous outcomes using
intraclass correlation. Standard definitions were used for test-
ing characteristics including sensitivity, specificity, positive
predictive value, and negative predictive value (13). Multivari-
able logistic regression was used to identify a subset of
electrocardiographic predictors best able to discriminate
ARVD/C ventricular arrhythmias from RVOT. For electro-
cardiographic predictors that examined the same measurement
in all 12 leads, a Bonferroni correction was performed to
address multiple hypothesis testing (a p value cutoff of0.004
was therefore considered statistically significant for these uni-
variate analyses). For individual electrocardiographic character-
istics with a priori evidence suggesting utility as a predictor
(lead I QRS duration120 ms [14]), a 2-tailed p value0.05
was considered statistically significant in univariate analysis.
Beginning with 6 predictors with p  0.05 in single-predictor
odels, we screened models with 2-, 3-, and 4-predictor
odels using 5-fold cross-validation of the C-statistic, a
easure of discrimination. STATA version 10.0 (StataCorp,
ollege Station, Texas) was used for all statistical analyses.
esults
total of 59 ECGs demonstrating ventricular arrhythmias
ere analyzed. Seventeen were from the ARVD/C cohort.
leven of the 17 ECGs (65%) had revealed VT, and 6 of the o7 ECGs (35%) showed PVCs.
orty-two ECGs were from
VOT-VT patients, and 7 of
he 42 ECGs (17%) of the
VOT-VT group showed VT,
hereas the other 35 ECGs
83%) showed PVCs. The base-
ine noninvasive imaging charac-
eristics and presence of T-wave
nversions of the ARVD/C co-
ort are shown in Table 1. Only
of the 16 patients (25%) had
ransthoracic echocardiographic
ndings consistent with ARVD/C
ompared with 12 of 16 MRI
cans, computed tomography
cans, or right ventricular angio-
rams (75%) showing right ven-
ricular changes consistent with
RVD/C. The diagnosis of the other patients included a
trong family history (such as autopsy confirmation) to-
ether with abnormalities on the ECG and/or positive gene
utations associated with ARVD/C.
The mean and SD duration of the QRS complex in lead
was greater in ARVD/C patients than in those with
VOT-VT (150 31 ms vs. 123 34 ms, p 0.006) (Fig. 3).
We did not find any significant difference between
ARVD/C and RVOT-VT ECGs in QRS durations in
other leads or the earliest onset of QRS to peak/nadir
measurements.
Notching in at least 1 lead was more often observed in
ARVD/C ECGs compared with RVOT-VT ECGs (11
of 17 [65%] vs. 9 of 42 [21%], p  0.001). We also found
a significant preponderance of notching during the up-
stroke of the QRS complex in ARVD/C ECGs compared
with RVOT-VT ECGs (8 of 17 [47%] vs. 5 of 42 [12%],
p  0.003). The presence of multiple notches across
several leads was seen more often in the ARVD/C ECGs
compared with RVOT-VT ECGs (6 of 17 [35%] vs. 5 of
42 [12%], p  0.04).
Precordial transition at V6 or later was observed in 3 of 17
atients (18%) with ARVD/C and in none of the 42
atients with RVOT-VT (p  0.005). If V5 was used for
transition, 8 of 17 of the ARVD/C cohort (47%) had a
transition at V5 or later compared with only 4 of 42 patients
with RVOT-VT (9.5%) (p  0.001).
The most sensitive test was duration of QRS in lead I of
120 ms (88%). The QRS transition at V6 was the most
pecific (100%). The individual test characteristics are
hown in Table 2.
The intraobserver agreement between the 2 ECG readers
howed an intraclass coefficient with regard to the QRS
nset to V6 measurement of 0.60 (95% confidence interval:
.43 to 0.77) and a kappa value of 0.74 for the assessment
Abbreviations
and Acronyms
ARVD/C  arrhythmogenic
right ventricular
dysplasia/cardiomyopathy
ECG  electrocardiogram
LBBB  left bundle branch
block
MRI  magnetic resonance
imaging
OR  odds ratio
PVC  premature
ventricular contraction
RVOT-VT  right ventricular
outflow tract tachycardia
VT  ventricular
tachycardiaf QRS notching.
Q
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Electrocardiographic Comparison of ARVD/C and RVOT Arrhythmias August 16, 2011:831–8Using these electrocardiographic test characteristics,
we used univariate and multivariate logistic regression to
determine which variables were independent predictors
of ARVD/C. Because transition at V6 was had specificity
of 100% for ARVD/C, this variable fell out of the model.
For multivariate analysis, duration of QRS in lead I 120
ms (odds ratio [OR]: 20.4, p  0.034), earliest onset
RS on lead V1 (OR: 17.0, p  0.022), QRS notching
OR: 7.7, p  0.018), and transition V5 or later (OR: 7.0,
p  0.030) were all statistically significant. The specific
ORs, 95% confidence intervals, and p values are shown in
Table 3. A 5-fold cross-validation of the C-statistic, a
Figure 1 Examples of Measurements
Simultaneous recordings of a 12-lead electrocardiogram in a patient with right
ventricular outflow tract ventricular tachycardia demonstrating an example of
our measurements. The initial onset was in lead V2 (arrow), and it was used
as a baseline (long vertical line) for our measurement of initial onset to local
onset, where local onsets are marked as small vertical lines in the other leads
in the left column. The duration was 66 ms in lead I, 13 ms in lead II, and 13
ms in lead III. In the middle column, we measured the initial onset to peak/
nadir in each lead. This duration was 97 ms in aVR and 94 ms in aVL. In the
right column, we show examples of measurements of QRS duration. QRS dura-
tion in lead I measured 58 and 129 ms in V4.measure of discrimination, was 0.49 to 0.64 for thesingle-predictor models and 0.85 for the multivariate
model.
Using electrocardiographic criteria to distinguish the
site of origin of VT/PVCs previously published by Dixit
et al. (15) as well as the observed successful site of
ablation for the RVOT-VT group, we showed that
ARVD/C patients are more likely to have a free wall
(nonseptal) location (70.6% vs. 16.7%, p  0.001) (Table 4)
and the location of the free-wall site was mostly anterior
(52.9% vs. 9.5%, p  0.001). RVOT-VT patients were
more likely to have septal location (83.3% vs. 29.4%, p 
0.001).
Discussion
It is important to distinguish ventricular arrhythmias of an
LBBB QRS morphology/inferior axis ARVD/C ventricular
Figure 2 Examples of Notching
Example of multiple notching (arrows) during ventricular tachycardia
in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
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August 16, 2011:831–8 Electrocardiographic Comparison of ARVD/C and RVOT Arrhythmiasarrhythmia from those that occur due to RVOT-VT to
assist in differentiating these 2 conditions. To our knowl-
edge, this report consists of the largest cohort of patients
with ARVD/C with ventricular arrhythmias consisting of
ARVD/C Baseline Noninvasive CharacteristicsTable 1 ARVD/C Baseline Noninvasive Characteristics
Patient # Echocardiogram (Transthoracic)
1 Biatrial enlargement Right atr
2 Within normal limits Marked
with a
divert
3 Mild biatrial enlargement Within n
4 Within normal limits Within n
5 Severe right ventricular dysfunction, left ventricular dysfunction Moderat
6 Within normal limits Distal se
with d
7 Within normal limits Right ve
8 Within normal limits Within n
9 Within normal limits Focal thi
hypok
with m
10 Moderate right ventricular dilation with moderate
right ventricular dysfunction
Right ve
right
with f
11 Severe left atrial enlargement No fatty
apica
12 Within normal limits Severe r
13 Within normal limits Within n
14 Within normal limits Not avai
15 Dilated right ventricular, moderate dysfunction Not avai
16 Biventricular dysfunction, right ventricular enlargement Not avai
*Patient underwent computed tomography, not magnetic resonance imaging. †Patients 14 through
criteria (12). All other patients (1 to 13) were from the ARVD registry with confirmed diagnosis m
ARVD/C  arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Figure 3 Duration of QRS in Lead I in ARVD/C
Versus RVOT-VT
Boxplot showing the duration of lead I QRS in right ventricular outflow tract
tachycardia (RVOT-VT) versus arrhythmogenic right ventricular dysplasia/cardio-
myopathy (ARVD/C). The mean duration of the QRS complex in lead I was
greater in ARVD/C patients than those with RVOT-VT (150  31 ms vs. 123 
34 ms, p  0.006). The middle line represents the median (50th percentile),
each box boundary represents the 25th to 75th percentiles (interquartile
range).an LBBB with an inferior axis morphology. In this study,
we found that certain features of the QRS complex during
ventricular arrhythmias could assist in distinguishing
ARVD/C from idiopathic RVOT-VT. This is based on
several findings, such as a precordial transition at V5 or later,
he presence of notching on the QRS complex, and a QRS
uration in lead I of 120 ms. The most specific findings
ere late precordial transition (100% specificity at V6 and
90% specificity at V5 or later), and the most sensitive was
duration of QRS in lead I of 120 ms, followed by the
presence of any notching on the QRS complex (Fig. 4).
The differences observed in the QRS complexes in our
ARVD/C study population compared with our RVOT-VT
population may be due to 2 factors. The most important is
the replacement of normal right ventricular myocardial
tissue with fibrous and fatty tissue, which may delay
cell-to-cell conduction and facilitate the development of
re-entrant ventricular arrhythmias (16). We hypothesize
that this results in a greater delay from earliest onset to local
onset of the QRS complex, greater duration of the QRS
complex, and irregularities of conduction manifest as notch-
ing of the QRS complex. Another factor may be related to
a greater frequency of the site of origin of the right
ventricular free wall for patients with ARVD/C sites more
remote from the normal His-Purkinje conduction tissue
than in those patients with RVOT-VT. These factors also
explain the late precordial transition and possibly notching
Magnetic Resonance Imaging T-Wave Inversions
argement None
ulations of the right ventricle, irregular contour of the free wall
f myocardial thinning; small focal pouch or mildly aneurysmal
of the anterior right ventricular wall.
V1–V4
limits V1–V3
limits V1–V5
ion of right ventricle and right atrium None
fibrosis and thinning, no fatty tissue, enlarged right ventricle
sia
V1–V4
r wall thinning and trabeculation, no fatty infiltration None
limits V1–V4
of the free wall of the right ventricle with associated
; dilation of the right atrium and right ventricular outflow tract
lation of the right ventricle.
V1–V6, II, III, aVF
r dilation with areas of wall thinning; findings compatible with
ular aneurysms; transmural right ventricular fat in free wall
inning; hypokinesia and akinesia of the right ventricle.
V1–V5
tes, right ventricular apex dyskinesia and right ventricular
rysm
V1–V4
ntricular dilation, wall thinning, and hypokinesis with dysplasia None
limits* (computed tomography) V1–V3, III, aVF
V1–V4
V1–V4
V1–V6
d right ventricular angiograms performed that were consistent with ARVD/C by modified task force
the core laboratory.ial enl
trabec
reas o
iculum
ormal
ormal
e dilat
ptum
yskine
ntricula
ormal
nning
inesia
ild di
ntricula
ventric
ocal th
infiltra
l aneu
ight ve
ormal
lable†
lable†
lable†
16 haof the QRS. A number of studies have found that VT
Ty.
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Electrocardiographic Comparison of ARVD/C and RVOT Arrhythmias August 16, 2011:831–8origins in patients with RVOT-VT are predominantly in
the septum (6,15). Therefore, differences between electro-
cardiographic characteristics of ventricular arrhythmias in
patients with RVOT-VT versus ARVD/C are partially
explained by differences in the site of VT origin.
When we compared the site of VT origin with other
noninvasive data, we found important discrepancies be-
tween the site of VT origin compared with the location of
structural right ventricular abnormalities found by echocar-
diography or MRI (Table 1). Conceivably, current nonin-
vasive methodologies are not sufficiently sensitive to detect
the small areas of myocardial scarring associated with or
responsible for VT foci in the thin-walled right ventricle. At
the time that these MRI studies were performed, gadolin-
ium enhancement was not in routine use. Conceivably,
detection of scarring using this methodology would better
explain the discrepancies between site of VT origin and the
actual changes found on noninvasive imaging.
In the study by Ainsworth et al. (12), the electrocardio-
graphic tracings of VT from 20 ARVD/C patients were
compared with those from 24 patients with RVOT-VT.
They described several criteria of QRS duration and axis
that were helpful in distinguishing the 2 groups. Only 9
patients in that study had QRS complexes with an LBBB
with an inferior axis. For this specific group, increased QRS
duration in lead I helped differentiate patients with
ARVD/C from those with RVOT-VT. In addition, QRS
duration was longer in the inferior leads and in V1 to V3.
wo patients were found with a precordial transition at V6
or later, but it is not specified whether these patients were
among the 9 patients with an LBBB and an inferior axis. In
Test Characteristics for Identifying ARVD/CTable 2 Test Characteristics for Identifying
Test Algorithm
Specifi
%
Duration of QRS in lead I of 120 ms 4
Notching on QRS complex 7
Notching on upstroke of QRS 8
Multiple notching of the QRS across several leads 8
Earliest onset of QRS on lead V1 9
Transition at V6 or later 10
Transition at V5 or later 9
ARVD/C  arrhythmogenic right ventricular dysplasia/cardiomyopath
Univariate and Multivariate AnalysisTable 3 Univariate and Multivariate Analysis
Test Algorithm Univariate OR 95% C
Duration of QRS in lead I of 120 ms 6.82 1.38–33
Notching on QRS complex 6.72 1.95–23
Notching on upstroke of QRS 6.58 1.73–24
Multiple notching of the QRS across several leads 4.04 1.03–15
Earliest onset of QRS on lead V1 5.18 1.24–21
Transition at V5 or later† 8.44 2.08–34
*Using backward deletion of the variables with the highest p value, these variables were eliminate
significance for each is lost after multivariate adjustment. The C-statistic for the multivariate model was
CI  confidence interval; OR  odds ratio.our study, we were able to confirm that the duration of the
QRS in lead I was helpful in distinguishing between the 2
groups. Other discriminators were QRS notching and
precordial transition at V5 or later.
Multiple criteria are required to diagnose ARVD/C.
These include characteristic electrocardiographic as well as
morphological criteria (10,12,17). Our observations suggest
that electrocardiographic parameters may help guide the
clinician to the proper diagnosis. In addition, it is clear that
the initial echocardiographic evaluation (even when using
the recent revised suggestive criteria [18]) was very limited in
supporting the diagnosis of ARVD/C. The echocardiogram
was normal or equivocal in 12 of 16 patients (75%). Of interest,
the finding that T-wave inversions V1 to V3 of the 12-lead
ECG in sinus rhythm was found in 12 of 16 patients (75%),
suggesting that both the electrocardiographic findings de-
scribed for VT/PVCs as well as the surface ECG can be used
for useful noninvasive screening.
Study limitations. The sample size is relatively small
because this is a rare disease and we studied a subset of
patients with LBBB/inferior axis. To increase the sample
size for a more robust analysis, we included patients with
both VT and PVCs. Ainsworth et al. (14) analyzed a subset
of patients with PVCs and found identical findings com-
pared with those with VT. They concluded that measuring
PVC duration might represent a practical method of differ-
entiating the 2 entities and warrants future study. Because
our sample size is relatively small, there are limitations to
our multivariate analysis for electrocardiographic predictors
of ARVD/C, and the model is prone to overfitting. We also
/C
Sensitivity,
%
Positive
Predictive Value, %
Negative
Predictive Value, %
88 41 91
65 55 85
47 62 80
35 55 77
35 60 77
18 100 77
47 67 81
p Value C-Statistic Multivariate OR 95% CI p Value
0.018 0.63 20.38 1.25–33.32 0.034
0.003 0.64 6.67 1.38–32.10 0.018
0.006 0.59 * * *
0.045 0.49   
0.024 0.54 17.0 1.50–193.30 0.022
0.03 0.59 7.0 1.21–40.64 0.030
entially. The 3 notching variables are likely in part colinear and may be the reason that statisticalARVD
city,
8
9
8
8
0
0
0I
.59
.18
.97
.80
.70
.35
d sequ
0.85. †V6 transition has 100% specificity and accordingly cannot be used in logistic regression.
of
m
e
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August 16, 2011:831–8 Electrocardiographic Comparison of ARVD/C and RVOT Arrhythmiasrecognize that the 3 covariates related to QRS notching are
at least in part colinear and that may be the main reason that
statistical significance for each is lost after multivariable
adjustment. We realize that having 4 covariates violates the
VT/PVC Anatomic Localizationby Electroc rdiographyTable 4 VT/PVC Anatomic Localizationby Electrocardiography
Location
ARVD/C
(n  17)
RVOT-VT
(n  42) p Value
Free wall (total) 12 (70.6) 7 (16.7) 0.001
Anterior 9 (52.9) 4 (9.5) 0.001
Posterior 2 (11.8) 2 (4.8) 0.333
Inflow tract/His bundle region 1 (5.9) 1 (2.4) 0.501
Septal (total) 5 (29.4) 35 (83.3) 0.001
Anterior septal 4 (23.5) 16 (38.1) 0.128
Mid septal 0 9 (21.4) 0.038
Posterior septal 1 (5.9) 10 (23.8) 0.109
Values are n (%). Data from Dixit et al. (15).
ARVD/C  arrhythmogenic right ventricular dysplasia/cardiomyopathy; PVC  premature
ventricular contraction; RVOT-VT  right ventricular outflow tract ventricular tachycardia; VT 
ventricular tachycardia.
Figure 4 Characteristic Features
Twelve-lead electrocardiograms from patients with right ventricular outflow tract ta
opathy (ARVD/C) (D to H) showing characteristic features. (A) RVOT-VT from an an
lead I (78 ms). (B) RVOT-VT originating superior to His bundle region showing prec
RVOT-VT from a posterior-septal location showing precordial transition at V3 and n
ing late precordial transition V5, wide QRS duration in lead I (124 ms), and earlies
V6 and wide QRS duration in lead I (126 ms). (F) ARVD/C-VT shows very late prec
late precordial transition V5, wide QRS duration in lead I (160 ms), and notching o
(128 ms) and notching of the QRS (II, III, aVF, V to V ).4 6rule of 1 covariate per 10 outcomes, although a recent paper
suggests that this criterion may be too stringent (19);
however, we acknowledge that our ratio is quite small.
However, ARVD/C is a rare disease, and enrolling the
necessary number to comply with this rule is not feasible. In
addition, the C-statistic, a measure of discrimination, for
the 4-variable multivariate model is 0.85 compared with
0.49 to 0.64 for the univariate models, signifying an im-
proved prediction of the multivariate model. Although our
findings are statistically significant, many of the 95% con-
fidence intervals are wide. However, even in the setting of
these wide confidence intervals and even if the lowest value is
used, the odds of predicting ARVD/C are still clinically useful.
For example, the odds of having ARVD/C are at least 38%
greater if the duration of QRS in lead I is120 ms (lower limit
f 95% confidence interval OR: 1.38, p  0.034).
The methodology used in our report may be challenging
or routine application for some clinicians, but the measure-
ents can be done on any software system that has image
diting software with an appropriate selection tool. In
dia (RVOT-VT) (A to C) and arrhythmogenic right ventricular dysplasia/cardiomy-
-septal location showing precordial transition at V2 and narrow QRS duration in
transition at V4, positive R-wave in aVL, and narrow QRS in lead I (86 ms). (C)
RS duration in lead I (118 ms). (D) ARVD/C ventricular tachycardia (VT) show-
t QRS in V1 (vertical line). (E) ARVD/C-VT shows very late precordial transition
transition V6 and wide QRS duration in lead I (150 ms). (G) ARVD/C-VT shows
RS (II, III, aVF, V4 to V6). (H) ARVD/C-VT shows wide QRS duration in lead Ichycar
terior
ordial
arrow Q
t onse
ordial
f the Q
s
l
t
t
A
d
o
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include the options to line up all lead tracings and include
digital calipers for measurements (Philips Tracemaster MD,
Andover, Massachusetts). These measurements are readily
available with standard equipment used in the electrophys-
iology laboratory. Even in the absence of these tools, other
criteria such as notching and precordial transition can be
readily appreciated.
Conclusions
Several electrocardiographic criteria can help distinguish
ventricular arrhythmia originating from ARVD/C from
RVOT-VT. Precordial transition at lead V6 was exclusively
een in ARVD/C patients. QRS duration of 120 ms in
ead I was sensitive for the diagnosis of ARVD/C, whereas
he presence of notching in the QRS and precordial
ransition at lead V6 are specific for the diagnosis of
RVD/C. Multivariate logistic regression revealed that the
uration of QRS in lead I of 120 ms, earliest onset QRS
n lead V1, notching, and transition V5 or later all signifi-
cantly increased the odds of ARVD/C. A combination of
these factors helps in differentiating ARVD/C from
RVOT-VT.
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